Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Psoriasis
Related studies linked through entity extraction aliases.
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Assessment and Psychosocial Impact of Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE1
A Safety Study of Mirikizumab (LY3074828)
- Status
- COMPLETED
- Phase
- PHASE1
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
T and B Cell Responses in Autoimmune Diseases
- Status
- TERMINATED
- Phase
- N/A
Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects
- Status
- COMPLETED
- Phase
- PHASE1
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
- Status
- COMPLETED
- Phase
- N/A
Comparative Analysis of Small and Large Plaque Psoriasis
- Status
- COMPLETED
- Phase
- NA
Photocil (Topical) for the Treatment of Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- NA
Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Vitamin D Levels in Psoriasis Patients
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3